CSF
VictoryShares US Discovery Enhanced Volatility Wtd ETF
Investor Moves
News
proactiveinvestors.comPlus Therapeutics gains CAP accreditation for CNSide CSF assay platformproactiveinvestors.comJun 4
globenewswire.comPlus Therapeutics Receives AMA PLA Code for CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement and U.S. Commercial Adoptionglobenewswire.comApr 7
globenewswire.comPlus Therapeutics Secures Highmark Coverage for CNSide® CSF Assay, Expanding Reimbursement to ~75 Million Covered Livesglobenewswire.comApr 2
globenewswire.comGain Therapeutics Presents Additional Clinical and Biomarker Data from Phase 1b Clinical Study of GT-02287 and Preclinical Data from Novel Chemical Series at AD/PD 2026globenewswire.comMar 18